Therdose Pharma Private Limited — Irinotecan Exporter Profile
Indian Pharmaceutical Exporter · #14 for Irinotecan · $143.3K export value · DGFT Verified
Therdose Pharma Private Limited is the #14 Indian exporter of Irinotecan with $143.3K in export value and 21 verified shipments. Therdose Pharma Private Limited holds a 0.3% market share in Irinotecan exports across 6 countries. The company exports 4 pharmaceutical products worth $1.1M across 2 therapeutic categories.
Therdose Pharma Private Limited — Irinotecan Export Profile: Buyers & Destinations
Where Does Therdose Pharma Private Limited Export Irinotecan?
| Country | Value | Shipments | Share |
|---|---|---|---|
| PHILIPPINES | $128.6K | 13 | 81.4% |
| LEBANON | $19.0K | 2 | 12.0% |
| ZIMBABWE | $9.5K | 3 | 6.0% |
| SINGAPORE | $904 | 1 | 0.6% |
| KENYA | $11 | 1 | 0.0% |
| GAUTEMALA | $2 | 2 | 0.0% |
Therdose Pharma Private Limited exports Irinotecan to 6 countries. The largest destination is PHILIPPINES accounting for 81.4% of Therdose Pharma Private Limited's Irinotecan shipments, followed by LEBANON (12.0%) and ZIMBABWE (6.0%). These destinations reflect Therdose Pharma Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Irinotecan from Therdose Pharma Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| MEDETHIX INC | PHILIPPINES | $128.6K | 13 |
| ESSENCE LIFE | LEBANON | $19.0K | 2 |
| M/S. PLANET PHARMACEUTICALS | ZIMBABWE | $3.2K | 1 |
| M/S.RHAEGAL PHARMACEUTICALS | ZIMBABWE | $3.2K | 1 |
| M/S.PLANET PHARMACEUTICAL & | ZIMBABWE | $3.2K | 1 |
| WIN GENERAL RESOURCES PTE LTD., | SINGAPORE | $904 | 1 |
| PHARMA SPECIALITIES LIMITED | KENYA | $11 | 1 |
| GETICS S.A | GAUTEMALA | $2 | 2 |
Therdose Pharma Private Limited supplies Irinotecan to 8 buyers globally. The largest buyer is MEDETHIX INC (PHILIPPINES), followed by ESSENCE LIFE (LEBANON) and M/S. PLANET PHARMACEUTICALS (ZIMBABWE). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Irinotecan Export Value and How Much Does Therdose Pharma Private Limited Contribute?
India exported $37.5M worth of Irinotecan through 2,905 shipments from 164 suppliers to 111 countries, serving 495 buyers globally. Therdose Pharma Private Limited contributes $143.3K to this total, accounting for 0.3% of India's Irinotecan exports. Therdose Pharma Private Limited ships Irinotecan to 6 countries through 8 buyers.
What Is the Average Shipment Value for Therdose Pharma Private Limited's Irinotecan Exports?
Therdose Pharma Private Limited's average Irinotecan shipment value is $6.8K per consignment, based on 21 shipments totaling $143.3K. The largest destination is PHILIPPINES (81.4% of Therdose Pharma Private Limited's Irinotecan exports).
How Does Therdose Pharma Private Limited Compare to Other Indian Irinotecan Exporters?
Therdose Pharma Private Limited ranks #14 among 164 Indian Irinotecan exporters with a 0.3% market share. The top 3 exporters are INTAS PHARMACEUTICALS LIMITED ($14.7M), FRESENIUS KABI ONCOLOGY LIMITED ($10.4M), EUGIA PHARMA SPECIALITIES LIMITED ($4.4M). Therdose Pharma Private Limited processed 21 shipments to 6 destination countries.
What Irinotecan Formulations Does Therdose Pharma Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| IRINOTECAN HYDROCHLORIDE (AS TRIDYDRATE) | $44.4K | 3 |
| IRINOTECAN HYDROCHLORIDE (AS TRIHYDRATE)CONCENTRATE FOR SOLUTION FOR INFUSION (IV) 20MG/ML,(100MG/5ML) (IRNOTHER) | $29.3K | 2 |
| IRINOTECAN HYDROCHLORIDE (AS TRIHYDRATE) | $16.1K | 2 |
| IRINOTECAN HYDROCHLORIDE AS TRIHYDRATECONCENTRATE FOR SOLUTION FOR INFUSIONIV20MG/ML100MG/5ML IRNOTHER | $14.8K | 1 |
| Irinotecan Hydrochloride (as Trihydrate)Concentrate for Solution for Infusion (IV)20mg/ml, (100mg/5ml) (IRNOTHER) | $14.7K | 1 |
| Irinotecan Hydrochloride Injection USP 100mg (Irnother 100) 012032501D Mfg Dt.03/2025,Exp Dt.02/2026 | $9.5K | 1 |
| Irinotecan Hydrochloride Injection USP 100mg (Irnother 100) 012032501D Mfg Dt.03/2025,Exp Dt.02/2027 | $9.5K | 1 |
| IRINOTECAN (AS HYDROCHLORIDE ) CONCENTRATE FOR SOLUTION FOR INFUSION (IV)20MG/ML100MG/5ML (IREBENE 100) | $5.1K | 1 |
| IRINOTECAN HYDROCHLORIDE INJECTION USP | $3.2K | 1 |
| IRINOTECAN HCL INJECTION USP 100 MG (IRN | $3.2K | 1 |
Therdose Pharma Private Limited exports 17 distinct Irinotecan formulations including tablets, capsules, syrups, and combination drugs. The top formulation is IRINOTECAN HYDROCHLORIDE (AS TRIDYDRATE) with 3 shipments worth $44.4K.
How Does Therdose Pharma Private Limited Compare to Nearest Irinotecan Exporters?
Exporters ranked immediately above and below #14 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 12 | NAPROD LIFE SCIENCES PRIVATE LIMITED | $165.1K | 18 | 3 | $9.2K |
| 13 | EMCURE PHARMACEUTICALS LIMITED | $155.4K | 10 | 2 | $15.5K |
| 14 | THERDOSE PHARMA PRIVATE LIMITED ★ | $143.3K | 21 | 6 | $6.8K |
Therdose Pharma Private Limited ranks #14 among 164 Indian Irinotecan exporters. Average shipment value of $6.8K compared to the market average of $228.7K. The closest competitors by value are NAPROD LIFE SCIENCES PRIVATE LIMITED and EMCURE PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Irinotecan Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 300 | 10.3% |
| SAHAR AIR | 296 | 10.2% |
| AHEMDABAD AIR ACC (INAMD4) | 252 | 8.7% |
| MUNDRA SEA (INMUN1) | 217 | 7.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 207 | 7.1% |
| DELHI AIR | 205 | 7.1% |
| AHEMDABAD AIR | 205 | 7.1% |
| MUNDRA SEA | 152 | 5.2% |
What Other Oncology Products Does Therdose Pharma Private Limited Export?
Therdose Pharma Private Limited also exports these oncology products. Each links to the detailed product page.
About Therdose Pharma Private Limited
Therdose Pharma Private Limited exports 4 products worth $1.1M. Beyond Irinotecan, top products include Docetaxel, Carmustine, Pazopanib. View the complete Therdose Pharma Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Irinotecan — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Irinotecan shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Therdose Pharma Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 22 individual customs records matching Therdose Pharma Private Limited exporting Irinotecan, covering 17 formulations to 6 countries via 8 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 111+ countries, 495+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Irinotecan Export Data from Therdose Pharma Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Therdose Pharma Private Limited's Irinotecan exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Therdose Pharma Private Limited
Full Company Profile →
4 products · $1.1M total trade · 2 categories
Irinotecan Stats
Company Overview
Top Products by Therdose Pharma Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Therdose Pharma Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Irinotecan. For current shipment-level data, contact TransData Nexus.